A citation-based method for searching scientific literature

Giacomo Sgalla, Bruno Iovene, Mariarosaria Calvello, Margherita Ori, Francesco Varone, Luca Richeldi. Respir Res 2018
Times Cited: 128







List of co-cited articles
736 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management.
Ganesh Raghu, Harold R Collard, Jim J Egan, Fernando J Martinez, Juergen Behr, Kevin K Brown, Thomas V Colby, Jean-François Cordier, Kevin R Flaherty, Joseph A Lasky,[...]. Am J Respir Crit Care Med 2011
25

Idiopathic pulmonary fibrosis.
Luca Richeldi, Harold R Collard, Mark G Jones. Lancet 2017
453
22

Idiopathic Pulmonary Fibrosis.
David J Lederer, Fernando J Martinez. N Engl J Med 2018
416
21

A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis.
Talmadge E King, Williamson Z Bradford, Socorro Castro-Bernardini, Elizabeth A Fagan, Ian Glaspole, Marilyn K Glassberg, Eduard Gorina, Peter M Hopkins, David Kardatzke, Lisa Lancaster,[...]. N Engl J Med 2014
19

Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis.
Luca Richeldi, Roland M du Bois, Ganesh Raghu, Arata Azuma, Kevin K Brown, Ulrich Costabel, Vincent Cottin, Kevin R Flaherty, David M Hansell, Yoshikazu Inoue,[...]. N Engl J Med 2014
19

Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline.
Ganesh Raghu, Martine Remy-Jardin, Jeffrey L Myers, Luca Richeldi, Christopher J Ryerson, David J Lederer, Juergen Behr, Vincent Cottin, Sonye K Danoff, Ferran Morell,[...]. Am J Respir Crit Care Med 2018
18

Idiopathic pulmonary fibrosis.
Fernando J Martinez, Harold R Collard, Annie Pardo, Ganesh Raghu, Luca Richeldi, Moises Selman, Jeffrey J Swigris, Hiroyuki Taniguchi, Athol U Wells. Nat Rev Dis Primers 2017
294
14

Pathogenesis of idiopathic pulmonary fibrosis.
Paul J Wolters, Harold R Collard, Kirk D Jones. Annu Rev Pathol 2014
360
13

Inflammation and immunity in IPF pathogenesis and treatment.
P Heukels, C C Moor, J H von der Thüsen, M S Wijsenbeek, M Kool. Respir Med 2019
67
16

The Role of Immune and Inflammatory Cells in Idiopathic Pulmonary Fibrosis.
Omkar Desai, Julia Winkler, Maksym Minasyan, Erica L Herzog. Front Med (Lausanne) 2018
84
11

A common MUC5B promoter polymorphism and pulmonary fibrosis.
Max A Seibold, Anastasia L Wise, Marcy C Speer, Mark P Steele, Kevin K Brown, James E Loyd, Tasha E Fingerlin, Weiming Zhang, Gunnar Gudmundsson, Steve D Groshong,[...]. N Engl J Med 2011
608
10

An official American Thoracic Society/European Respiratory Society statement: Update of the international multidisciplinary classification of the idiopathic interstitial pneumonias.
William D Travis, Ulrich Costabel, David M Hansell, Talmadge E King, David A Lynch, Andrew G Nicholson, Christopher J Ryerson, Jay H Ryu, Moisés Selman, Athol U Wells,[...]. Am J Respir Crit Care Med 2013
10

An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline: Treatment of Idiopathic Pulmonary Fibrosis. An Update of the 2011 Clinical Practice Guideline.
Ganesh Raghu, Bram Rochwerg, Yuan Zhang, Carlos A Cuello Garcia, Arata Azuma, Juergen Behr, Jan L Brozek, Harold R Collard, William Cunningham, Sakae Homma,[...]. Am J Respir Crit Care Med 2015
940
9

Global incidence and mortality of idiopathic pulmonary fibrosis: a systematic review.
John Hutchinson, Andrew Fogarty, Richard Hubbard, Tricia McKeever. Eur Respir J 2015
334
9

Idiopathic Pulmonary Fibrosis (IPF): An Overview.
Shaney L Barratt, Andrew Creamer, Conal Hayton, Nazia Chaudhuri. J Clin Med 2018
87
10

The pathogenesis of pulmonary fibrosis: a moving target.
Wim A Wuyts, Carlo Agostini, Katerina M Antoniou, Demosthenes Bouros, Rachel C Chambers, Vincent Cottin, Jim J Egan, Bart N Lambrecht, Rik Lories, Helen Parfrey,[...]. Eur Respir J 2013
148
9


Idiopathic pulmonary fibrosis.
Talmadge E King, Annie Pardo, Moisés Selman. Lancet 2011
9

Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials.
Paul W Noble, Carlo Albera, Williamson Z Bradford, Ulrich Costabel, Marilyn K Glassberg, David Kardatzke, Talmadge E King, Lisa Lancaster, Steven A Sahn, Javier Szwarcberg,[...]. Lancet 2011
9

Prednisone, azathioprine, and N-acetylcysteine for pulmonary fibrosis.
Ganesh Raghu, Kevin J Anstrom, Talmadge E King, Joseph A Lasky, Fernando J Martinez. N Engl J Med 2012
854
8

Epithelial⁻Mesenchymal Transition in the Pathogenesis of Idiopathic Pulmonary Fibrosis.
Francesco Salton, Maria Concetta Volpe, Marco Confalonieri. Medicina (Kaunas) 2019
46
17

Genetic variants associated with idiopathic pulmonary fibrosis susceptibility and mortality: a genome-wide association study.
Imre Noth, Yingze Zhang, Shwu-Fan Ma, Carlos Flores, Mathew Barber, Yong Huang, Steven M Broderick, Michael S Wade, Pirro Hysi, Joseph Scuirba,[...]. Lancet Respir Med 2013
304
7

Antifibrotic and anti-inflammatory activity of the tyrosine kinase inhibitor nintedanib in experimental models of lung fibrosis.
Lutz Wollin, Isabelle Maillet, Valérie Quesniaux, Alexander Holweg, Bernhard Ryffel. J Pharmacol Exp Ther 2014
295
7

BIBF 1120: triple angiokinase inhibitor with sustained receptor blockade and good antitumor efficacy.
Frank Hilberg, Gerald J Roth, Martin Krssak, Susanna Kautschitsch, Wolfgang Sommergruber, Ulrike Tontsch-Grunt, Pilar Garin-Chesa, Gerd Bader, Andreas Zoephel, Jens Quant,[...]. Cancer Res 2008
674
7

Developmental pathways in the pathogenesis of lung fibrosis.
Diptiman Chanda, Eva Otoupalova, Samuel R Smith, Thomas Volckaert, Stijn P De Langhe, Victor J Thannickal. Mol Aspects Med 2019
79
8

Mechanisms of fibrosis: therapeutic translation for fibrotic disease.
Thomas A Wynn, Thirumalai R Ramalingam. Nat Med 2012
6

TOLLIP, MUC5B, and the Response to N-Acetylcysteine among Individuals with Idiopathic Pulmonary Fibrosis.
Justin M Oldham, Shwu-Fan Ma, Fernando J Martinez, Kevin J Anstrom, Ganesh Raghu, David A Schwartz, Eleanor Valenzi, Leah Witt, Cathryn Lee, Rekha Vij,[...]. Am J Respir Crit Care Med 2015
156
6

Genome-wide association study identifies multiple susceptibility loci for pulmonary fibrosis.
Tasha E Fingerlin, Elissa Murphy, Weiming Zhang, Anna L Peljto, Kevin K Brown, Mark P Steele, James E Loyd, Gregory P Cosgrove, David Lynch, Steve Groshong,[...]. Nat Genet 2013
414
6

An Official American Thoracic Society Workshop Report: Use of Animal Models for the Preclinical Assessment of Potential Therapies for Pulmonary Fibrosis.
R Gisli Jenkins, Bethany B Moore, Rachel C Chambers, Oliver Eickelberg, Melanie Königshoff, Martin Kolb, Geoffrey J Laurent, Carmel B Nanthakumar, Mitchell A Olman, Annie Pardo,[...]. Am J Respir Cell Mol Biol 2017
119
6


Matrix abnormalities in pulmonary fibrosis.
Chandak Upagupta, Chiko Shimbori, Rahmah Alsilmi, Martin Kolb. Eur Respir Rev 2018
54
11

Metformin reverses established lung fibrosis in a bleomycin model.
Sunad Rangarajan, Nathaniel B Bone, Anna A Zmijewska, Shaoning Jiang, Dae Won Park, Karen Bernard, Morgan L Locy, Saranya Ravi, Jessy Deshane, Roslyn B Mannon,[...]. Nat Med 2018
180
6

Metformin induces lipogenic differentiation in myofibroblasts to reverse lung fibrosis.
Vahid Kheirollahi, Roxana M Wasnick, Valentina Biasin, Ana Ivonne Vazquez-Armendariz, Xuran Chu, Alena Moiseenko, Astrid Weiss, Jochen Wilhelm, Jin-San Zhang, Grazyna Kwapiszewska,[...]. Nat Commun 2019
63
9

A multidimensional index and staging system for idiopathic pulmonary fibrosis.
Brett Ley, Christopher J Ryerson, Eric Vittinghoff, Jay H Ryu, Sara Tomassetti, Joyce S Lee, Venerino Poletti, Matteo Buccioli, Brett M Elicker, Kirk D Jones,[...]. Ann Intern Med 2012
582
6

Mode of action of nintedanib in the treatment of idiopathic pulmonary fibrosis.
Lutz Wollin, Eva Wex, Alexander Pautsch, Gisela Schnapp, Katrin E Hostettler, Susanne Stowasser, Martin Kolb. Eur Respir J 2015
332
6

Genetic variants associated with susceptibility to idiopathic pulmonary fibrosis in people of European ancestry: a genome-wide association study.
Richard J Allen, Joanne Porte, Rebecca Braybrooke, Carlos Flores, Tasha E Fingerlin, Justin M Oldham, Beatriz Guillen-Guio, Shwu-Fan Ma, Tsukasa Okamoto, Alison E John,[...]. Lancet Respir Med 2017
114
6

Safety, tolerability, pharmacokinetics, and pharmacodynamics of GLPG1690, a novel autotaxin inhibitor, to treat idiopathic pulmonary fibrosis (FLORA): a phase 2a randomised placebo-controlled trial.
Toby M Maher, Ellen M van der Aar, Olivier Van de Steen, Lisa Allamassey, Julie Desrivot, Sonia Dupont, Liesbeth Fagard, Paul Ford, Ann Fieuw, Wim Wuyts. Lancet Respir Med 2018
99
6

Pulmonary fibrosis and COVID-19: the potential role for antifibrotic therapy.
Peter M George, Athol U Wells, R Gisli Jenkins. Lancet Respir Med 2020
313
6

Association between the MUC5B promoter polymorphism and survival in patients with idiopathic pulmonary fibrosis.
Anna L Peljto, Yingze Zhang, Tasha E Fingerlin, Shwu-Fan Ma, Joe G N Garcia, Thomas J Richards, Lori J Silveira, Kathleen O Lindell, Mark P Steele, James E Loyd,[...]. JAMA 2013
267
5


Simple method of estimating severity of pulmonary fibrosis on a numerical scale.
T Ashcroft, J M Simpson, V Timbrell. J Clin Pathol 1988
885
5

High levels of IL-6 and IL-8 characterize early-on idiopathic pulmonary fibrosis acute exacerbations.
Spyros A Papiris, Ioannis P Tomos, Anna Karakatsani, Aris Spathis, Ioanna Korbila, Antonis Analitis, Likurgos Kolilekas, Konstantinos Kagouridis, Stylianos Loukides, Petros Karakitsos,[...]. Cytokine 2018
52
9

Novel Mechanisms for the Antifibrotic Action of Nintedanib.
Sunad Rangarajan, Ashish Kurundkar, Deepali Kurundkar, Karen Bernard, Yan Y Sanders, Qiang Ding, Veena B Antony, Jianhua Zhang, Jaroslaw Zmijewski, Victor J Thannickal. Am J Respir Cell Mol Biol 2016
91
5

Anti-fibrotic effects of nintedanib in lung fibroblasts derived from patients with idiopathic pulmonary fibrosis.
Katrin E Hostettler, Jun Zhong, Eleni Papakonstantinou, George Karakiulakis, Michael Tamm, Petra Seidel, Qingzhu Sun, Jyotshna Mandal, Didier Lardinois, Christopher Lambers,[...]. Respir Res 2014
129
5

Antifibrotic action of pirfenidone and prednisolone: different effects on pulmonary cytokines and growth factors in bleomycin-induced murine pulmonary fibrosis.
Hisashi Oku, Toshikatsu Shimizu, Tomoji Kawabata, Morio Nagira, Ichiro Hikita, Azumi Ueyama, Shuuichi Matsushima, Mikinori Torii, Akinori Arimura. Eur J Pharmacol 2008
260
5

Alveolar epithelial cell mesenchymal transition develops in vivo during pulmonary fibrosis and is regulated by the extracellular matrix.
Kevin K Kim, Matthias C Kugler, Paul J Wolters, Liliane Robillard, Michael G Galvez, Alexis N Brumwell, Dean Sheppard, Harold A Chapman. Proc Natl Acad Sci U S A 2006
891
5

Myofibroblast contraction activates latent TGF-beta1 from the extracellular matrix.
Pierre-Jean Wipff, Daniel B Rifkin, Jean-Jacques Meister, Boris Hinz. J Cell Biol 2007
826
5

Nintedanib for Systemic Sclerosis-Associated Interstitial Lung Disease.
Oliver Distler, Kristin B Highland, Martina Gahlemann, Arata Azuma, Aryeh Fischer, Maureen D Mayes, Ganesh Raghu, Wiebke Sauter, Mannaig Girard, Margarida Alves,[...]. N Engl J Med 2019
368
5

Cigarette smoking: a risk factor for idiopathic pulmonary fibrosis.
K B Baumgartner, J M Samet, C A Stidley, T V Colby, J A Waldron. Am J Respir Crit Care Med 1997
435
5

miR-21 mediates fibrogenic activation of pulmonary fibroblasts and lung fibrosis.
Gang Liu, Arnaud Friggeri, Yanping Yang, Jadranka Milosevic, Qiang Ding, Victor J Thannickal, Naftali Kaminski, Edward Abraham. J Exp Med 2010
653
5


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.